Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Trial offers hope for koala chlamydia vaccine
koala
“Chlamydia is one of the major threats to our koala populations".

Scientists report world's first successful trial involving wild koalas

Australian scientists have carried out the world's first successful trial of a vaccine against chlamydia in koala bears.

Microbiologists from the University of Sunshine Coast (USC) in Queensland have spent five years leading the research. In previous studies, the team trialled the vaccine on captive koalas, but for the past year they have been testing its effects in wild animals.

Sixty koalas were captured from their natural habitat in the Moreton Bay region north of Brisbane. Half were vaccinated, while the remaining thirty were left unvaccinated as a control group. Each koala was fitted with a radio tag for monitoring purposes.

Professor Timms, who led the research, said the results were "very promising". The vaccinated koalas showed good immune responses and lower levels of chlamydia infection than the unvaccinated group.

“This large trial has confirmed that the vaccine is safe to give to not only captive koalas, but also koalas in the wild,” he said.

However, the trial will continue for at least another year. The team hope to show the vaccine's positive impacts on disease and female reproductivity, as well as infection.

Professor Timms also hopes to assess the vaccine's impact on other koala populations facing the threat of chlamydial disease, but this will require further funding.

“We feel compelled to start using this vaccine more broadly, especially when we know that it is safe and has some definite positive benefit to the animals,” he said.

“But a project of this size and cost requires a large team of people, including veterinarians and field teams, in addition to the laboratory aspects.”

The Queensland Government provided funding of $358,000 to the trial. State environment minister Andrew Powell said: “Chlamydia is one of the major threats to our koala populations and that’s why we’ve invested significant funds into combating this disease.

“Among other things, chlamydia in koalas can lead to blindness and infertility, so it’s clear why we need to support research that can stem these conditions.”
A special fund has been set up for those wishing to offer donations to the project:
http://www.usc.edu.au/community/giving-to-usc/giving-opportunities/koala-research-project

To watch a video of the researchers discussing their work, visit: http://www.youtube.com/watch?v=yrfbHfO76e0&feature=youtu.be

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
Applications open for BEVA Back in the Saddle

The British Equine Veterinary Association (BEVA) has opened applications for its 'Back in the Saddle' coaching programme.

The online scheme offers structured group coaching for members wanting to reflect on their career path and regain clarity. Members may be returning to work after leave, uncertain about next steps or reassessing direction.

Attendees will benefit from impartial guidance and practical tools to support their professional development. Members are encouraged to take a 'proactive, future-focused approach' to their careers.

The sessions, taking place on Wednesdays from 7.30pm-9pm, are open to BEVA members with more than five years' experience. The first session takes place on Wednesday, 3 June 2026.

Applications will close on Wednesday, 27 May 2026.